News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merck & Co., Inc. (MRK) Says Clot Preventer has Bleeding Risk


1/20/2011 7:01:19 AM

Reuters -- Merck & Co's experimental blood clot preventer vorapaxar can cause bleeding in patients who previously suffered a stroke, the drugmaker confirmed on Wednesday. Merck said last week that an independent committee to monitor clinical trials of the drug determined that vorapaxar was inappropriate for patients with a history of strokes.

Read at Reuters
Read at Wall Street Journal
Read at Bloomberg
Read at Forbes


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES